
Ifosfamide
| Product/Composition:- | Ifosfamide |
|---|---|
| Strength:- | 1000mg |
| Form | Injection |
| Production Capacity | 100000 injections |
| Therapeutic use | Anti Cancer |
| Package Insert/Leaflet | Available upon request |
Ifosfamide
-
Type: Anticancer (chemotherapy) drug
-
Drug Class: Alkylating agent (nitrogen mustard derivative)
-
Form: Sterile powder or solution for intravenous (IV) infusion
How It Works
-
Ifosfamide is a prodrug that gets activated in the liver by cytochrome P450 enzymes.
-
The active metabolites form DNA cross-links within cancer cells, preventing DNA replication and transcription.
-
This leads to cell cycle arrest and cell death, particularly in rapidly dividing tumor cells.
Common Uses
Ifosfamide is widely used for:
-
Testicular cancer (especially in refractory or relapsed cases)
-
Soft tissue sarcomas
-
Lung cancer (small cell and non-small cell)
-
Cervical cancer
-
Ovarian cancer
-
Lymphomas
-
Pediatric tumors (such as Wilms’ tumor, rhabdomyosarcoma, Ewing’s sarcoma)
Administration
-
Given intravenously over several hours, often as part of combination chemotherapy regimens
-
Always co-administered with Mesna (a uroprotectant) to prevent hemorrhagic cystitis caused by toxic metabolites
Advantages
-
Effective against a wide range of solid tumors and hematologic cancers
-
Can be combined with other chemotherapy agents for improved response rates
-
Can be used in both adults and children under supervision
Possible Side Effects
Common:
-
Nausea, vomiting, loss of appetite
-
Hair loss (alopecia)
-
Low white blood cell counts (neutropenia) → risk of infection
-
Fatigue
Important/Rare but Serious:
-
Hemorrhagic cystitis (bladder bleeding) – prevented with Mesna
-
Kidney toxicity (tubular damage, electrolyte imbalances)
-
Neurotoxicity (confusion, drowsiness, seizures – reversible but serious)
-
Risk of secondary malignancies with prolonged use
Precautions
-
Hydration is essential to flush out toxic metabolites and protect the bladder
-
Kidney function and electrolytes should be monitored regularly
-
Blood counts must be monitored before each cycle
-
Avoid use during pregnancy (risk of fetal harm)
-
Patients should report neurological symptoms (confusion, hallucinations) immediately